Literature DB >> 14517056

Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor.

Hideki Aizaki1, Seishi Nagamori, Mami Matsuda, Hayato Kawakami, Osamu Hashimoto, Hiroaki Ishiko, Masaaki Kawada, Tomokazu Matsuura, Satoshi Hasumura, Yoshiharu Matsuura, Tetsuro Suzuki, Tatsuo Miyamura.   

Abstract

Lack of efficient culture systems for hepatitis C virus (HCV) has been a major obstacle in HCV research. Human liver cells grown in a three-dimensional radial-flow bioreactor were successfully infected following inoculation with plasma from an HCV carrier. Subsequent detection of increased HCV RNA suggested viral replication. Furthermore, transfection of HCV RNA transcribed from full-length cDNA also resulted in the production and release of HCV virions into supernatant. Infectivity was shown by successful secondary passage to a new culture. Introduction of mutations in RNA helicase and polymerase regions of HCV cDNA abolished virus replication, indicating that reverse genetics of this system is possible. The ability to replicate and detect the extracellular release of HCV might provide clues with regard to the persistent nature of HCV infection. It will also accelerate research into the pathogenicity of HCV, as well as the development of prophylactic agents and new therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517056     DOI: 10.1016/s0042-6822(03)00383-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

Review 1.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

Review 2.  Bioreactors for 3-dimensional high-density culture of human cells.

Authors:  Tomokazu Matsuura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

3.  Reconstruction of liver organoid using a bioreactor.

Authors:  Masaya Saito; Tomokazu Matsuura; Takahiro Masaki; Haruka Maehashi; Keiko Shimizu; Yoshiaki Hataba; Tohru Iwahori; Tetsuro Suzuki; Filip Braet
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

4.  New Methods in Tissue Engineering: Improved Models for Viral Infection.

Authors:  Vyas Ramanan; Margaret A Scull; Timothy P Sheahan; Charles M Rice; Sangeeta N Bhatia
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

5.  All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP.

Authors:  Takahiro Masaki; Tomokazu Matsuura; Kiyoshi Ohkawa; Tatsuo Miyamura; Isao Okazaki; Tetsu Watanabe; Tetsuro Suzuki
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

6.  Novel permissive cell lines for complete propagation of hepatitis C virus.

Authors:  Mai Shiokawa; Takasuke Fukuhara; Chikako Ono; Satomi Yamamoto; Toru Okamoto; Noriyuki Watanabe; Takaji Wakita; Yoshiharu Matsuura
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

7.  Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly.

Authors:  Kevin C Klein; Stephen J Polyak; Jaisri R Lingappa
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Identification of basal promoter and enhancer elements in an untranslated region of the TT virus genome.

Authors:  Tetsuro Suzuki; Ryosuke Suzuki; Jin Li; Minako Hijikata; Mami Matsuda; Tiang-Cheng Li; Yoshiharu Matsuura; Shunji Mishiro; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 9.  Engineered Livers for Infectious Diseases.

Authors:  Nil Gural; Liliana Mancio-Silva; Jiang He; Sangeeta N Bhatia
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-11-22

10.  The Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion.

Authors:  Loïc Etienne; Emmanuelle Blanchard; Audrey Boyer; Virginie Desvignes; Julien Gaillard; Jean-Christophe Meunier; Philippe Roingeard; Christophe Hourioux
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.